Request for Information; Clinical Research Infrastructure and Emergency Clinical Trials; Correction, 68206 [2022-24666]

Download as PDF 68206 Federal Register / Vol. 87, No. 218 / Monday, November 14, 2022 / Notices International Service contract to the list of Negotiated Service Agreements in the Competitive Product List in the Mail Classification Schedule. DATES: Date of notice: November 14, 2022. FOR FURTHER INFORMATION CONTACT: [FR Doc. 2022–24666 Filed 11–10–22; 8:45 am] BILLING CODE 3270–F1–P Christopher C. Meyerson, (202) 268– 7820. SECURITIES AND EXCHANGE COMMISSION The United States Postal hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on November 3, 2022, it filed with the Postal Regulatory Commission a USPS Request to Add Priority Mail Express International, Priority Mail International & First-Class Package International Service Contract 10 to Competitive Product List. Documents are available at www.prc.gov, Docket Nos. MC2023–32 and CP2023–31. [Release No. 34–96246; File No. SR–OCC– 2022–011] SUPPLEMENTARY INFORMATION: Service® Ruth Stevenson, Chief Counsel, Ethics and Legal Compliance. [FR Doc. 2022–24622 Filed 11–10–22; 8:45 am] BILLING CODE 7710–12–P OFFICE OF SCIENCE AND TECHNOLOGY POLICY Request for Information; Clinical Research Infrastructure and Emergency Clinical Trials; Correction Office of Science and Technology Policy (OSTP). ACTION: Notice of Request for Information (RFI); Correction. AGENCY: The Office of Science and Technology Policy published a document in the Federal Register of October 25, 2022, concerning a request for information on Clinical Research Infrastructure and Emergency Clinical Trials. This document corrects an error in that notice. FOR FURTHER INFORMATION CONTACT: Scott Weaver, 202–456–4444. SUPPLEMENTARY INFORMATION: SUMMARY: Correction khammond on DSKJM1Z7X2PROD with NOTICES Dated: October 8, 2022. Rachel Wallace, Deputy General Counsel. In the Federal Register of October 25, 2022, in FR Doc. 2022–23110, on page 64823, in the third column, in the first paragraph i., correct the first sentence to read: i. As described above and in the forthcoming RFI on data capture, we are seeking information on how to create a pilot program enabling clinical trial data collection across a wide variety of trial sites that is easy for health care providers to use and can be scaled up for use in emergency research settings. VerDate Sep<11>2014 17:30 Nov 10, 2022 Jkt 259001 Self-Regulatory Organizations; The Options Clearing Corporation; Notice of Filing and Immediate Effectiveness of Proposed Rule Change by The Options Clearing Corporation Concerning Corrections to Its By-Laws November 7, 2022. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Exchange Act’’ or ‘‘Act’’),1 and Rule 19b–4 thereunder,2 notice is hereby given that on October 24, 2022, The Options Clearing Corporation (‘‘OCC’’) filed with the Securities and Exchange Commission (‘‘SEC’’ or ‘‘Commission’’) the proposed rule change as described in Items I, II, and III below, which Items have been prepared primarily by OCC. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. I. Clearing Agency’s Statement of the Terms of Substance of the Proposed Rule Change This proposed rule change would amend OCC’s By-Laws to (i) correct an inadvertent omission and typographical error in a prior rule filing and (ii) correct an erroneous cross-reference and make other conforming changes consistent with a reorganization effected by another prior proposed rule change. Amendments to OCC’s By-Laws and Rules are included in Exhibit 5 of filing SR–OCC–2022–011. Material proposed to be added is marked by underlining, and material proposed to be deleted is marked with strikethrough text. All terms with initial capitalization that are not otherwise defined herein have the same meaning as set forth in the ByLaws and Rules.3 II. Clearing Agency’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change In its filing with the Commission, OCC included statements concerning 1 15 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 OCC’s By-Laws and Rules can be found on OCC’s public website: https://www.theocc.com/ Company-Information/Documents-and-Archives/ By-Laws-and-Rules. 2 17 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. OCC has prepared summaries, set forth in sections (A), (B), and (C) below, of the most significant aspects of these statements. (A) Clearing Agency’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change (1) Purpose As a self-regulatory organization (‘‘SRO’’) that is registered as a covered clearing agency under the Securities Exchange Act of 1934 (‘‘Exchange Act’’), as amended,4 and a derivatives clearing organization (‘‘DCO’’) under the Commodity Exchange Act,5 OCC files proposed changes to its rules with the SEC and the Commodity Futures Trading Commission (‘‘CFTC’’), including changes to OCC’s By-Laws and Rules.6 SEC and CFTC regulations require that SROs maintain clear and transparent governance arrangements.7 In order to enhance the clarity and transparency of its By-Laws, OCC is proposing amendments that would (1) correct an inadvertent omission and typographical error introduced by a prior rule filing and (2) correct an erroneous cross-reference and make other conforming changes consistent with a reorganization effected by another prior proposed rule change. 1. Typographical Error Correction First, OCC has identified an inadvertent omission and typographical error in the text of a prior proposed rule change submitted to the SEC: • The reference to ‘‘Treasurer’’ in Article IV, Section 2 would be replaced with ‘‘Chief Financial Officer,’’ consistent with the intent of the proposed rule change (SR–OCC–2021– 010) that amended Section 11 of that Article to address the appointment and responsibilities of a Chief Financial Officer, rather than a Treasurer.8 • OCC would also amend Section 11 of Article IV (Chief Financial Officer), to correct an inadvertent reference to ‘‘Chief Compliance Officer,’’ rather than 4 15 U.S.C. 78s. U.S.C. 7a–1. 6 See 17 CFR 240.19b–4 (SRO proposed rule changes filed with the SEC); 17 CFR 40.6 (DCO selfcertifications filed with the CFTC). 7 See 17 CFR 240.17Ad–22(e)(2)(i) (with respect to governance arrangements of covered clearing agencies); 17 CFR 39.24(a)(1)(iii) [sic] (with respect to DCO governance arrangements). 8 See Exchange Act Release No. 93436 (Oct. 27, 2021), 86 FR 60499, 60500 (Nov. 2, 2021) (SR–OCC– 2021–010). 57 E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 87, Number 218 (Monday, November 14, 2022)]
[Notices]
[Page 68206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24666]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF SCIENCE AND TECHNOLOGY POLICY


Request for Information; Clinical Research Infrastructure and 
Emergency Clinical Trials; Correction

AGENCY: Office of Science and Technology Policy (OSTP).

ACTION: Notice of Request for Information (RFI); Correction.

-----------------------------------------------------------------------

SUMMARY: The Office of Science and Technology Policy published a 
document in the Federal Register of October 25, 2022, concerning a 
request for information on Clinical Research Infrastructure and 
Emergency Clinical Trials. This document corrects an error in that 
notice.

FOR FURTHER INFORMATION CONTACT: Scott Weaver, 202-456-4444.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of October 25, 2022, in FR Doc. 2022-23110, 
on page 64823, in the third column, in the first paragraph i., correct 
the first sentence to read:
    i. As described above and in the forthcoming RFI on data capture, 
we are seeking information on how to create a pilot program enabling 
clinical trial data collection across a wide variety of trial sites 
that is easy for health care providers to use and can be scaled up for 
use in emergency research settings.

    Dated: October 8, 2022.
Rachel Wallace,
Deputy General Counsel.
[FR Doc. 2022-24666 Filed 11-10-22; 8:45 am]
BILLING CODE 3270-F1-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.